David Cordani - Mar 1, 2024 Form 4 Insider Report for Cigna Group (CI)

Role
Chairman & CEO, Director
Signature
Matthew Arnold, attorney-in-fact
Stock symbol
CI
Transactions as of
Mar 1, 2024
Transactions value $
-$14,059,519
Form type
4
Date filed
3/5/2024, 05:43 PM
Previous filing
Mar 1, 2024
Next filing
Mar 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +35.9K +10.37% $0.00 383K Mar 1, 2024 Direct F1
transaction CI Common Stock, $.01 Par Value Tax liability -$2.09M -6.27K -1.64% $333.36 376K Mar 1, 2024 Direct F2
transaction CI Common Stock, $.01 Par Value Tax liability -$5.55M -16.7K -4.43% $333.36 360K Mar 1, 2024 Direct F3
transaction CI Common Stock, $.01 Par Value Sale -$6.42M -19.3K -5.36% $332.62 340K Mar 4, 2024 Direct F4
holding CI Common Stock, $.01 Par Value 1.73K Mar 1, 2024 By 401(k) F5
holding CI Common Stock, $.01 Par Value 99.9K Mar 1, 2024 By GRAT
holding CI Common Stock, $.01 Par Value 154K Mar 1, 2024 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
F2 Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
F3 Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
F4 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.
F5 Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.